Skip to main navigation Skip to search Skip to main content

Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study

  • Funda Meric-Bernstam
  • , Emiliano Calvo
  • , Keun Seok Lee
  • , Victor Moreno
  • , Yeon Hee Park
  • , Sun Young Rha
  • , Pavani Chalasani
  • , Wei Zhong
  • , Li Zhou
  • , Steven Pirie-Shepherd
  • , Abraham C.F. Leung
  • , Giuseppe Curigliano

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases